Agonist-induced regulation and trafficking of κ opioid receptors

Life Sciences

Volumn 75, Issue 5, 2004, Pages 511-536

  Liu Chen, Lee Yuan ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Desensitization; Down regulation; Internalization; Phosphorylation; opioid receptor

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ADENYLATE CYCLASE; BETA ARRESTIN; BREMAZOCINE; DYNORPHIN; ETORPHINE; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; MITOGEN ACTIVATED PROTEIN KINASE; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE;

BIOCHEMISTRY; BRAIN; DESENSITIZATION; DOWN REGULATION; ENZYME ACTIVITY; GUINEA PIG; HUMAN; MOLECULAR CLONING; NONHUMAN; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; REGULATORY MECHANISM; SHORT SURVEY; SPECIES DIFFERENCE;

CAVIA PORCELLUS; SUS SCROFA;

EID: 2442678807     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.10.041     Document Type: Review

References (121)

1. Adler M.W., Geller E.B. Physiological functions of opioids: temperature regulation. Herz A. Handbook of Experimental Pharmacology. vol. 104/II Opioids II:1993;205-238 Springer-Verlag, Berlin
2. Afify E.A., Law P.-Y., Riedl M., Elde R., Loh H.H. Role of carboxyl terminus of mu-and delta-opioid receptor in agonist-induced down-regulation. Brain Research Molecular Brain Research. 54:1998;24-34
3. Appleyard S.M., Celver J., Pineda V., Kovoor A., Wayman G.A., Chavkin C. Agonist-dependent desensitization of the kappa opioid receptor by G protein receptor kinase and beta-arrestin. Journal of Biological Chemistry. 274:1999;23802-23807
4. Appleyard S.M., Patterson T.A., Jin W.Z., Chavkin C. Agonist-induced phosphorylation of the kappa-opioid receptor. Journal of Neurochemistry. 69:1997;2405-2412
5. Arden J.R., Segredo V., Wang Z., Lameh J., Sadee W. Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged mu-opioid receptor expressed in HEK 293 cells. Journal of Neurochemistry. 65:1995;1636-1645
6. Attali B., Saya D., Vogel Z. Kappa-opiate agonists inhibit adenylate cyclase and produce heterologous desensitization in rat spinal cord. Journal of Neurochemistry. 52:1989;360-369
7. Attali B., Vogel Z. Characterization of κ opiate receptors in rat spinal cord-dorsal root ganglion cocultures and their regulation by chronic opiate treatment. Brain Research. 517:1990;182-188
8. Avidor-Reiss T., Zippel R., Levy R., Saya D., Ezra V., Barg J., Matus-Leibovitch N., Vogel Z. Kappa-opioid receptor-transfected cell lines: modulation of adenylyl cyclase activity following acute and chronic opioid treatments. FEBS Letters. 361:1995;70-74
9. Bausch S.B., Esteb T.M., Terman G.W., Chavkin C. Administered and endogenously released kappa opioids decrease pilocarpine-induced seizures and seizure-induced histopathology. Journal of Pharmacology and Experimental Therapeutics. 284:1998;1147-1155
10. Belcheva M.M., Szucs M., Wang D., Sadee W., Coscia C.J. mu-Opioid receptor-mediated ERK activation involves calmodulin- dependent epidermal growth factor receptor transactivation. Journal of Biological Chemistry. 276:2001;33847-33853
11. Bhargava H.N., Gulati A. Kappa opioid receptor activity in spontaneously hypertensive rats. Journal of Pharmacology and Experimental Therapeutics. 245:1988;460-465
12. Bhargava H.N., Gulati A., Ramarao P. Effect of chronic administration of U-50, 488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord. Journal of Pharmacology and Experimental Therapeutics. 251:1989;21-26
13. Blake A.D., Bot G., Freeman J.C., Reisine T. Differential opioid agonist regulation of the mouse mu opioid receptor. Journal of Biological Chemistry. 272:1997;782-790
14. Blake A.D., Bot G., Li S.X., Freeman J.C., Reisine T. Differential agonist regulation of the human kappa-opioid receptor. Journal of Neurochemistry. 68:1997;1846-1852
15. Bohn L.M., Belcheva M.M., Coscia C.J. Evidence for kappa- and mu-opioid receptor expression in C6 glioma cells. Journal of Neurochemistry. 70:1998;1819-1825
16. Bohn L.M., Belcheva M.M., Coscia C.J. mu-opioid agonist inhibition of kappa-opioid receptor-stimulated extracellular signal-regulated kinase phosphorylation is dynamin-dependent in C6 glioma cells. Journal of Neurochemistry. 74:2000;574-581
17. Bohn L.M., Gainetdinov R.R., Lin F.T., Lefkowitz R.J., Caron M.G. Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature. 408:2000;720-723
18. Bohn L.M., Lefkowitz R.J., Caron M.G. Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice. Journal of Neuroscience. 22:2002;10494-10500
19. Bohn L.M., Lefkowitz R.J., Gainetdinov R.R., Peppel K., Caron M.G., Lin F.T. Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science. 286:1999;2495-2498
20. Borgland S.L. Acute opioid receptor desensitization and tolerance: is there a link? Clinical and Experimental Pharmacology and Physiology. 28:2001;147-154
21. Cao T.T., Deacon H.W., Reczek D., Bretscher A., von Zastrow M. A kinase-regulated PDZ-domain interaction controls endocytic sorting of the beta2-adrenergic receptor. Nature. 401:1999;286-290
22. Cen B., Xiong Y., Ma L., Pei G. Direct and differential interaction of beta-arrestins with the intracellular domains of different opioid receptors. Molecular Pharmacology. 59:2001;758-764
23. Chang K.-J. Opioid receptors: multiplicity and sequelae of ligand-receptor interactions. Conn P.M. The Receptors. vol. 1:1984;1-81 Academic Press, Inc. New York, NY
24. Chaturvedi K., Bandari P., Chinen N., Howells R.D. Proteasome involvement in agonist-induced down-regulation of mu and delta opioid receptors. Journal of Biological Chemistry. 276:2001;12345-12355
25. Cheng Z.J., Yu Q.M., Wu Y.L., Ma L., Pei G. Selective interference of beta-arrestin 1 with kappa and delta but not mu opioid receptor/G protein coupling. Journal of Biological Chemistry. 273:1998;24328-24333
26. Chu P., Murray S., Lissin D., von Zastrow M. Delta and kappa opioid receptors are differentially regulated by dynamin-dependent endocytosis when activated by the same alkaloid agonist. Journal of Biological Chemistry. 272:1997;27124-27130
27. Cong M., Perry S.J., Hu L.A., Hanson P.I., Claing A., Lefkowitz R.J. Binding of the beta2 adrenergic receptor to N-ethylmaleimide-sensitive factor regulates receptor recycling. Journal of Biological Chemistry. 276:2001;45145-45152
28. Cvejic S., Trapaidze N., Cyr C., Devi L.A. Thr353, located within the COOH-terminal tail of the delta opiate receptor, is involved in receptor down-regulation. Journal of Biological Chemistry. 271:1996;4073-4076
29. Daaka Y., Luttrell L.M., Ahn S., Dellarocca G.J., Ferguson S.S.G., Caron M.G., Lefkowitz R.J. Essential role for G protein-coupled receptor endocytosis in the activation of mitogen-activated protein kinase. Journal of Biological Chemistry. 273:1998;685-688
30. DeGraff J.L., Gagnon A.W., Benovic J.L., Orsini M.J. Role of arrestins in endocytosis and signaling of alpha2-adrenergic receptor subtypes. Journal of Biological Chemistry. 274:1999;11253-11259
31. Devi L.A. Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking. Trends Pharmacol Sci. 22:2001;532-537
32. Dykstra L.A., Gmerek D.E., Winger G., Woods J.H. Kappa opioids in Rhesus monkeys. I. diuresis, sedation, analgesia and discriminative stimulus effects. Journal of Pharmacology and Experimental Therapeutics. 242:1987;413-420
33. Evans C.J., Keith D.E., Morrison H., Magendzo K., Edwards R.H. Cloning of a delta opioid receptor by functional expression. Science. 258:1992;1952-1955
34. Finn A.K., Whistler J.L. Endocytosis of the mu opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal. [see comments] Neuron. 32:2001;829-839
35. Gagnon A.W., Kallal L., Benovic J.L. Role of clathrin-mediated endocytosis in agonist-induced downregulation of the beta2-adrenergic receptor. Journal of Biological Chemistry. 273:1998;6976-6981
36. Ghozland S., Matthes H.W., Simonin F., Filliol D., Kieffer B.L., Maldonado R. Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors. Journal of Neuroscience. 22:2002;1146-1154
37. Gmerek D.E., Cowan A. Role of opioid receptors in bombesin-induced grooming. Annals of the New York Academy of Sciences. 525:1988;291-300
38. Haberstock-Debic H., Wein M., Barrot M., Colago E.E., Rahman Z., Neve R.L., Pickel V.M., Nestler E.J., von Zastrow M., Svingos A.L. Morphine acutely regulates opioid receptor trafficking selectively in dendrites of nucleus accumbens neurons. Journal of Neuroscience. 23:2003;4324-4332
39. Hall R.A., Premont R.T., Chow C.W., Blitzer J.T., Pitcher J.A., Claing A., Stoffel R.H., Barak L.S., Shenolikar S., Weinman E.J., Grinstein S., Lefkowitz R.J. The beta2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange. Nature. 392:1998;626-630
40. Hall R.A., Ostedgaard L.S., Premont R.T., Blitzer J.T., Rahman N., Welsh M.J., Lefkowitz R.J. A C-terminal motif found in the beta2-adrenergic receptor, P2Y1 receptor and cystic fibrosis transmembrane conductance regulator determines binding to the Na+/H+ exchanger regulatory factor family of PDZ proteins. Proceedings of the National Academy of Sciences of the United States of America. 95:1998;8496-8501
41. He L., Fong J., von Zastrow M., Whistler J.L. Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization. Cell. 108:2002;271-282
42. Henry D.J., Grandy D.K., Lester H.A., Davidson N., Chavkin C. Kappa-opioid receptors couple to inwardly rectifying potassium channels when coexpressed by Xenopus oocytes. Molecular Pharmacology. 47:1995;551-557
43. Hicke L. Gettin' down with ubiquitin: turning off cell-surface receptors, transporters and channels. Trends in Cell Biology. 9:1999;107-112
44. Ignatova E.G., Belcheva M.M., Bohn L.M., Neuman M.C., Coscia C.J. Requirement of receptor internalization for opioid stimulation of mitogen-activated protein kinase: biochemical and immunofluorescence confocal microscopic evidence. Journal of Neuroscience. 19:1999;56-63
45. Innamorati G., Le Gouill C., Balamotis M., Birnbaumer M. The long and the short cycle. Alternative intracellular routes for trafficking of G-protein-coupled receptors. Journal of Biological Chemistry. 276:2001;13096-13103
46. Iwata K., Ito K., Fukuzaki A., Inaki K., Haga T. Dynamin and rab5 regulate GRK2-dependent internalization of dopamine D2 receptors. European Journal of Biochemistry. 263:1999;596-602
47. Jin W., Terman G.W., Chavkin C. Kappa opioid receptor tolerance in the guinea pig hippocampus. Journal of Pharmacology and Experimental Therapeutics. 281:1997;123-128
48. Jordan B.A., Cvejic S., Devi L.A. Kappa opioid receptor endocytosis by dynorphin peptides. DNA and Cell Biology. 19:2000;19-27
49. Joseph D.B., Bidlack J.M. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line down-regulates without desensitizing during chronic opioid exposure. Journal of Pharmacology and Experimental Therapeutics. 272:1995;970-976
50. Kallal L., Gagnon A.W., Penn R.B., Benovic J.L. Visualization of agonist-induced sequestration and down-regulation of a green fluorescent protein-tagged beta(2)-adrenergic receptor. Journal of Biological Chemistry. 273:1998;322-328
51. Keith D.E., Anton B., Murray S.R., Zaki P.A., Chu P.C., Lissin D.V., Monteillet-Agius G., Stewart P.L., Evans C.J., von Zastrow M. mu-Opioid receptor internalization: opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain. Molecular Pharmacology. 53:1998;377-384
52. Keith D.E., Murray S.R., Zaki P.A., Chu P.C., Lissin D.V., Kang L., Evans C.J., von Zastrow M. Morphine activates opioid receptors without causing their rapid internalization. Journal of Biological Chemistry. 271:1996;19021-19024
53. Kieffer B., Befort K., Gaveriaux-Ruff C., Hirth C.G. The δ-opioid receptor: Isolation of a cDNA by expression cloning and pharmacological characterization. [published erratum appears in Proc.Natl.Acad. Sci.U.S.A. 1994 Feb 1; 91 (3):1193] Proceedings of the National Academy of Sciences of the United States of America. 89:1992;12048-12052
54. Kieffer B.L. Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides. [review] Cellular and Molecular Neurobiology. 15:1995;615-635
55. Kieffer B.L., Evans C.J. Opioid tolerance-in search of the holy grail. Cell. 108:2002;587-590
56. Knapp R.J., Malatynska E., Collins N., Fang L., Wang J.Y., Hruby V.J., Roeske W.R., Yamamura H.I. Molecular biology and pharmacology of cloned opioid receptors. [review] FASEB Journal. 9:1995;516-525
57. Ko J.L., Arvidsson U., Williams F.G., Law P.-Y., Elde R., Loh H.H. Visualization of time-dependent redistribution of delta-opioid receptors in neuronal cells during prolonged agonist exposure. Molecular Brain Research. 69:1999;171-185
58. Krupnick J.G., Santini F., Gagnon A.W., Keen J.H., Benovic J.L. Modulation of the arrestin-clathrin interaction in cells - characterization of beta-arrestin dominant-negative mutants. Journal of Biological Chemistry. 272:1997;32507-32512
59. Law P.-Y., Hom D.S., Loh H.H. Down-regulation of opiate receptor in neuroblastoma x glioma NG108-15 hybrid cells: Chloroquine promotes accumulation of tritiated enkephalin in the lysosomes. Journal of Biological Chemistry. 259:1984;4096-4104
60. Law P.-Y., Louie A.K., Loh H.H. Effect of pertussis toxin treatment on down-regulation of opiate receptors in neuroblastoma x glioma NG108-15 hybrid cells. Journal of Biological Chemistry. 260:1985;14818-14823
61. Law P.-Y., Wong Y.H., Loh H.H. Molecular mechanisms and regulation of opioid receptor signaling. Annual Review of Pharmacology and Toxicology. 40:2000;389-430
62. Lawrence D.M.P., Bidlack J.M. Kappa opioid binding sites on the R1.1 murine lymphoma cell line: Sensitivity to cations and guanine nucleotides. Journal of Neuroimmunology. 41:1992;223-230
63. Lefkowitz R.J. G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization. [Review] [47 refs] Journal of Biological Chemistry. 273:1998;18677-18680
64. Li J., Li J.G., Chen C., Zhang F., Liu-Chen L.-Y. Molecular basis of differences in (-)(trans)-3, 4-dichloro-N-methyl-N-[2-(1-pyrrolidiny)- cyclohexyl]benzeneacetamide-induced desensitization and phosphorylation between human and rat κ-opioid receptors expressed in Chinese hamster ovary cells. Molecular Pharmacology. 61:2002;73-84
65. Li J.G., Benovic J.L., Liu-Chen L.-Y. Mechanisms of agonist-induced down-regulation of the human kappa-opioid receptor: internalization is required for down-regulation. Molecular Pharmacology. 58:2000;795-801
66. Li J.G., Chen C., Liu-Chen L.Y. Ezrin-radixin-moesin-binding phosphoprotein-50/Na+/H+ exchanger regulatory factor (EBP50/NHERF) blocks U50, 488H-induced down-regulation of the human kappa opioid receptor by enhancing its recycling rate. Journal of Biological Chemistry. 277:2002;27545-27552
67. Li J.G., Luo L.Y., Krupnick J.G., Benovic J.L., Liu-Chen L.-Y. U50, 488H-induced internalization of the human kappa opioid receptor involves a beta-arrestin- and dynamin-dependent mechanism. Kappa receptor internalization is not required for mitogen-activated protein kinase activation. Journal of Biological Chemistry. 274:1999;12087-12094
68. Li J.-G., Zhang F., Jin X., Liu-Chen L.-Y. Differential regulation of the human κ opioid receptor by agonists: Etorphine and levorphanol reduced dynorphin A- and U50, 488H-induced internalization and phosphorylation of the human κ opioid receptor. Journal of Pharmacology and Experimental Therapeutics. 305:2003;531-540
69. Li S., Zhu J., Chen C., Chen Y.-W., de Riel J.K., Ashby B., Liu-Chen L.-Y. Molecular cloning and expression of a rat κ opioid receptor. Biochem. J. 295:1993;629-633
70. Ling K., Ma L., Pei G. Differential efficacies of kappa agonists to induce homologous desensitization of human kappa opioid receptor. Neuroscience Letters. 240:1998;25-28
71. Mansour A., Khachaturian H., Lewis M.E., Akil H., Watson S.J. Anatomy of CNS opioid receptors. Trends in Neurosciences. 11:1988;308-314
72. Marchese A., Benovic J.L. Agonist-promoted Ubiquitination of the G Protein-coupled Receptor CXCR4 Mediates Lysosomal Sorting. Journal of Biological Chemistry. 276:2001;45509-45512
73. Marvizon J.C., Grady E.F., Waszak-McGee J., Mayer E.A. Internalization of mu-opioid receptors in rat spinal cord slices. Neuroreport. 10:1999;2329-2334
74. McLaughlin J.P., Myers L.C., Zarek P.E., Caron M.G., Lefkowitz R.J., Traci A., Pintar J.E., Chavkin C. Prolonged kappa-opioid receptor phosphorylation mediated by G-protein receptor kinase underlies sustained analgesic tolerance. Journal of Biological Chemistry. 279:2004;1810-1818
75. McLaughlin J.P., Xu M., Mackie K., Chavkin C. Phosphorylation of a carboxy-terminal serine within the kappa opioid receptor produces desensitization an internalization. Journal of Biological Chemistry. 278:2003;34631-34640
76. Moore R.H., Sadovnikoff N., Hoffenberg S., Liu S., Woodford P., Angelides K., Trial J.A., Carsrud N.D., Dickey B.F., Knoll B.J. Ligand-stimulated beta 2-adrenergic receptor internalization via the constitutive endocytic pathway into rab5-containing endosomes. Journal of Cell Science. 108:1995;2983-2991
77. Morris B.J., Herz A. Control of opiate receptor number in vivo: Simultaneous κ-receptor down-regulation and μ-receptor up-regulation following chronic agonist/antagonist treatment. Neuroscience. 29:1989;433-442
78. Murray C., Cowan A. Neuroadaptation of rats to kappa agonists U-50, 488 and tifluadom. NIDA Research Monograph. 81:1988;136-142
79. Nestler E.J. Molecular basis of long-term plasticity underlying addiction. Nature Reviews Neuroscience. 2:2001;119-128
80. Olkkonen V.M., Stenmark H. Role of Rab GTPases in membrane traffic. [Review] [360 refs] International Review of Cytology. 176:1997;1-85
81. Petaja-Repo U.E., Hogue M., Laperriere A., Bhalla S., Walker P., Bouvier M. Newly synthesized human delta opioid receptors retained in the endoplasmic reticulum are retrotranslocated to the cytosol, deglycosylated, ubiquitinated, and degraded by the proteasome. Journal of Biological Chemistry. 276:2001;4416-4423
82. Petaja-Repo U.E., Hogue M., Laperriere A., Walker P., Bouvier M. Export from the endoplasmic reticulum represents the limiting step in the maturation and cell surface expression of the human delta opioid receptor. Journal of Biological Chemistry. 275:2000;13727-13736
83. Pfeiffer A., Brantl V., Herz A., Emrich H.M. Psychotomimesis mediated by kappa opiate receptors. Science. 233:1986;774-776
84. Reece P.A., Sedman A.J., Rose S., Wright D.S., Dawkins R., Rajagopalan R. Diuretic effects, pharmacokinetics, and safety of a new centrally acting kappa-opioid agonist (CI-977) in humans. Journal of Clinical Pharmacology. 34:1994;1126-1132
85. Roth B.L., Baner K., Westkaemper R., Siebert D., Rice K.C., Steinberg S., Ernsberger P., Rothman R.B. Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proceedings of the National Academy of Sciences of the United States of America. 99:2002;11934-11939
86. Saras J., Heldin C.H. PDZ domains bind carboxy-terminal sequences of target proteins. Trends in Biochemical Sciences. 21:1996;455-458
87. Schramm N.L., Limbird L.E. Stimulation of mitogen-activated protein kinase by G protein-coupled alpha(2)-adrenergic receptors does not require agonist-elicited endocytosis. Journal of Biological Chemistry. 274:1999;24935-24940
88. Schulz R., Wehmeyer A., Schulz K. Visualizing preference of G protein-coupled receptor kinase 3 for the process of kappa-opioid receptor sequestration. Molecular Pharmacology. 61:2002;1444-1452
89. Schwartz T.W., Holst B. Molecular Structure of G Protein-Coupled Receptors. Foreman J.C., Johansen T. Textbook of Receptor Pharmacology. 2002;81-110 CRC press, New York
90. Seachrist J.L., Laporte S.A., Dale L.B., Babwah A.V., Caron M.G., Anborgh P.H., Ferguson S.S. Rab5 association with the angiotensin II type 1A receptor promotes Rab5 GTP binding and vesicular fusion. Journal of Biological Chemistry. 277:2002;679-685
91. Sharma S.K., Klee W.A., Nirenberg M. Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proceedings of the National Academy of Sciences of the United States of America. 72:1975;3092-3096
92. Sheng M., Sala C. PDZ domains and the organization of supramolecular complexes. Annual Review of Neuroscience. 24:2001;1-29
93. Shenoy S.K., McDonald P.H., Kohout T.A., Lefkowitz R.J. Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin. Science. 294:2001;1307-1313
94. Shippenberg T.S., Chefer V.I., Zapata A., Heidbreder C.A. Modulation of the behavioral and neurochemical effects of psychostimulants by kappa-opioid receptor systems. Annals of the New York Academy of Sciences. 937:2001;50-73
95. Siebert D.J. Salvia divinorum and salvinorin A: new pharmacologic findings. J. Ethnopharmacol. 43:1994;53-56
96. Simonin F., Valverde O., Smadja C., Slowe S., Kitchen I., Dierich A., Le M., Roques B.P., Maldonado R., Kieffer B.L. Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50, 488H and attenuates morphine withdrawal. EMBO Journal. 17:1998;886-897
97. Simons K., Zerial M. Rab proteins and the road maps for intracellular transport. [Review] [108 refs] Neuron. 11:1993;789-799
98. Sterne-Marr R., Benovic J.L. Regulation of G protein-coupled receptors by receptor kinases and arrestins. [review] Vitamins and Hormones. 51:1995;193-234
99. Sternini C., Spann M., Anton B., Keith D.E., Bunnett N.W., von Zastrow M., Evans C., Brecha N.C. Agonist-selective endocytosis of mu opioid receptor by neurons in vivo. Proceedings of the National Academy of Sciences of the United States of America. 93:1996;9241-9246
100. Tallent M., Dichter M.A., Reisine T. Differential regulation of the cloned kappa and mu opioid receptors. Neuroscience. 85:1998;873-885
101. Tanowitz M., von Zastrow M. Ubiquitination-independent trafficking of G protein-coupled receptors to lysosomes. Journal of Biological Chemistry. 277:2002;50219-50222
102. Taub D.D., Eisenstein T.K., Geller E.B., Adler M.W., Rogers T.J. Immunomodulatory activity of μ- and κ-selective opioid agonists. Proceedings of the National Academy of Sciences of the United States of America. 88:1991;360-364
103. Trafton J.A., Abbadie C., Marek K., Basbaum A.I. Postsynaptic signaling via the [mu]-opioid receptor: responses of dorsal horn neurons to exogenous opioids and noxious stimulation. Journal of Neuroscience. 20:2000;8578-8584
104. Trejo J., Coughlin S.R. The cytoplasmic tails of protease-activated receptor-1 and substance P receptor specify sorting to lysosomes versus recycling. Journal of Biological Chemistry. 274:1999;2216-2224
105. Tsao P.I., von Zastrow M. Type-specific sorting of G protein-coupled receptors after endocytosis. Journal of Biological Chemistry. 275:2000;11130-11140
106. van der Bliek A.M., Redelmeier T.E., Damke H., Tisdale E.J., Meyerowitz E.M., Schmid S.L. Mutations in human dynamin block an intermediate stage in coated vesicle formation. Journal of Cell Biology. 122:1993;553-563
107. VonVoigtlander P.F., Lahti R.A., Ludens J.H. U-50, 488: a selective and structurally novel non-Mu (kappa) opioid agonist. Journal of Pharmacology and Experimental Therapeutics. 224:1983;7-12
108. Wang Y., Li J.-G., Huang P., Xu W., Liu-Chen L.-Y. Differential effects of agonists on adenylyl cyclase superactivation mediated by the κ opioid receptors: Adenylyl cyclase superactivation is independent of agonist-induced phosphorylation, desensitization, internalization and down-regulation. Journal of Pharmacology and Experimental Therapeutics. 307:2003;1127-1134
109. Wang Y., Zhou Y., Szabo K., Haft C.R., Trejo J. Down-regulation of protease-activated receptor-1 is regulated by sorting nexin 1. Molecular Biology of the Cell. 13:2002;1965-1976
110. Wheeler-Aceto H., Cowan A. Standardization of the rat paw formalin test for the evaluation of analgesics. Psychopharmacology (Berlin). 104:1991;35-44
111. Whistler J.L., Enquist J., Marley A., Fong J., Gladher F., Tsuruda P., Murray S.R., von Zastrow M. Modulation of postendocytic sorting of G protein-coupled receptors. [see comments] Science. 297:2002;615-620
112. Whistler J.L., von Zastrow M. Dissociation of functional roles of dynamin in receptor-mediated endocytosis and mitogenic signal transduction. Journal of Biological Chemistry. 274:1999;24575-24578
113. Xia Q., Sheng J.Z., Tai K.K., Wong T.M. Effects of chronic U50, 488H treatment on binding and mechanical responses of the rat hearts. Journal of Pharmacology and Experimental Therapeutics. 268:1994;930-934
114. Xie G., Meng F., Mansour A., Thompson R.C., Hoversten M.T., Goldstein A., Watson S.J., Akil H. Primary structure and functional expression of a guinea pig κ opioid (dynorphin) receptor. Proceedings of the National Academy of Sciences of the United States of America. 91:1994;3779-3783
115. Yasuda K., Raynor K., Kong H., Breder C.D., Takeda J., Reisine T., Bell G.I. Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. Proceedings of the National Academy of Sciences of the United States of America. 90:1993;6736-6740
116. Yu Y.K., Zhang L., Yin X.X., Sun H., Uhl G.R., Wang J.B. Mu-opioid receptor phosphorylation, desensitization, and ligand efficacy. Journal of Biological Chemistry. 272:1997;28869-28874
117. Zhang F., Li J., Li J.G., Liu-Chen L.-Y. (-)U50, 488H [(trans)-3, 4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]benzeneace tamide] induces internalization and down-regulation of the human, but not the rat, kappa-opioid receptor: Structural basis for the differential regulation. Journal of Pharmacology and Experimental Therapeutics. 302:2002;1184-1192
118. Zhang J., Ferguson S.S., Barak L.S., Bodduluri S.R., Laporte S.A., Law P.-Y., Caron M.G. Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. Proceedings of the National Academy of Sciences of the United States of America. 95:1998;7157-7162
119. Zhu J., Chen C., Xue J.-C., Kunapuli S., de Riel J.K., Liu-Chen L.-Y. Cloning of a human κ opioid receptor from the brain. Life Sciences. 56:1995;PL201-PL207
120. Zhu J., Luo L.Y., Mao G.F., Ashby B., Liu-Chen L.-Y. Agonist-induced desensitization and down-regulation of the human kappa opioid receptor expressed in CHO cells. Journal of Pharmacology and Experimental Therapeutics. 285:1998;28-36
121. 35S]GTPγS binding to membranes: Determination of potencies and efficacies of ligands. Journal of Pharmacology and Experimental Therapeutics. 282:1997;676-684